0.00Open21.50Pre Close0 Volume0 Open Interest100.00Strike Price0.00Turnover3174.40%IV1.73%PremiumDec 27, 2024Expiry Date20.12Intrinsic Value100Multiplier-5DDays to Expiry1.39Extrinsic Value100Contract SizeAmericanOptions Type-0.9951Delta0.0021Gamma3.72Leverage Ratio-16.0367Theta0.0000Rho-3.70Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet